搜索结果
疾病ID:TCMBANKDI022227
疾病名:Salmonella infections
MeSH_Name:Infections
HPO_Name:-
UMLS_Name:Disease or Syndrome
DO_Name:-
疾病类型:group
DisGeNET_Link:C0036117
MeSH_Link:C01
HPO_Link:-
UMLS_Link:T047
DO_Link:-
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN061570 | curcumin | (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; C10443; BSPBio_003590; NCGC00095321-01; Curcumin; KBio3_003004; InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4+,16-13; curcumin ; diferuloylmethane; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; Kacha haldi; (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one; ZINC00899824; 458-37-7; SDCCGMLS-0066836.P001; SCHEMBL2622435; Spectrum3_001990; DivK1c_006683; KBio1_001627; SpecPlus_000587; SPBio_001728; Spectrum2_001714; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one; NSC32982; Turmeric oleoresin (79%-85% curcumin); Yellow Root; Halad; Diferaloylmethane; kachs haldi; safra d'inde; Curcumin, 95% (total curcuminoid content), from Turmeric rhizome; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; GTPL7000; Turmeric, oleoresin; CI 75300; MFCD00008365; curcuma longa l. root oil hydrodistilled; DSSTox_CID_1421; NSC-687842; C21H20O6; Merita earth; NCGC00017159-11; 1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; NCGC00017159-06; I06-2497; BDBM50140172; I14-19358; MLS001148449; LS-125; NCGC00023332-04; SCHEMBL8441; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one; BIDD:ER0479; 458-37-7; Turmeric root oil; Tox21_111505; BDBM50067040; 1790-EP2308861A1; Safran d'Inde; Turmeric oil (Curcuma longa L.); NSC 687842; Tumeric yellow; NCGC00017159-05; Curcuma oil; (1E,6E)-1,7-bis[4-hydroxy-3-(methyloxy)phenyl]hepta-1,6-diene-3,5-dione; 2,7-Nonadiene-4,6-dione, 1,9-bis(4-hydroxy-3-methoxyphenyl)-; EINECS 207-280-5; 15845-47-3; E 100; Curcuma longa l. oleoresin; Curcuma longa l. root oleoresin; SR-01000000149-2; NCGC00017159-10; D0H8LC; HMS3649K06; Turmeric oleoresin; Orange Root; Curcumin (Natural); Indian saffron; Curcumin, United States Pharmacopeia (USP) Reference Standard; NCGC00017159-07; CCG-36107; Curcumin solution, ~0.1 % (w/v) (in ethanol with 2M HCl (99:1 v/v)), for TLC derivatization; 5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one; Curcurmin; 1,5-Di(vanillyliden)acetylaceton; I06-0010; Natural yellow 3; SMR000058237; cid_969516; Zlut prirodni 3; CHEMBL140; CAS-458-37-7; Curcumin, analytical standard; BG0601; ZX-AT003872; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione #; BCP9000557; Yellow puccoon; Tumeric oleoresin; DB11672; 1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione; BG00706978; NSC687842; AC1LJ6T6; SCHEMBL8440; SR-01000000149; Tox21_201116; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; J10108; C.I. Natural Yellow 3; (1E,4Z,6E)-5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one; Curcumin (synthetic); BIC8500; NCGC00017159-09; CCRIS 5804; NCGC00023332-05; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; W-5038; 1,7-DI(4-HYDROXY-3-METHOXYPHENYL)HEPTA-1,6-DIENE-3; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, (E,E)-; FEMA No. 3086; 1790-EP2305629A1; BB_NC-01422; BC678109; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-; WLN: 1OR BQ E1U1V1V1U1R DQ CO1; Yellow Ginger; Diferuloylmethane; BRN 2306965; Bio-0677; AC1Q46A0; 98% curcurmin); cid_5281767; ZINC899824; Oils, galangal; 33171-04-9; (1E,6E)-1,7-bis(3-methoxy-4-oxidanyl-phenyl)hepta-1,6-diene-3,5-dione; curcuma longa l. root oil CO2 extract; Gelbwurz; OR24598; Oil of turmeric; Curcuma oil (Curcuma longa); MLS000069631; 1,5-Divanillyliden-2,4-pentandion; BDBM29532; 1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-heptadiene-3,5-dione; UNII-IT942ZTH98; Yellow, Turmeric; BCP0726000035; Tox21_110803; KB-251224; CU-01000001305-2; Turmeric oil; HMS2233K04; D07SDQ; ST055629; Curcumin, primary pharmaceutical reference standard; CCG-36020; BRD-K07572174-001-19-6; MolPort-001-763-682; DSSTox_GSID_31077; DSSTox_RID_78861; Turmeric; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-; NSC-32982; Kacha haldi; HY-N0005; Kurkumin [Czech]; Haldar; PREVENTION 4 (CURCUMIN) (SEE ALSO TUMERIC, OLEORESIN (10105-J)); (1Z,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; Turmeric (>98% curcurmin); GP8291; M212; Zlut prirodni 3 [Czech]; VFLDPWHFBUODDF-FCXRPNKRSA-N; LS-2189; Turmeric yellow; Turmeric extract (Curcuma longa L.); Curcumin; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; TR-032605; Curcuma longa l. root oil; FEMA No. 3085; curouma; Tu rmeric root oil; Opera_ID_1627; AC-24238; 73729-23-4; Halud; 1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; RTR-032605; Yo-Kin; NCGC00023332-03; trans,trans-Curcumin; Curcuma longa l. oil; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)-; IT942ZTH98; (E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; diferuloylmethan; cMAP_000052; N1839; 1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; BG01656528; Curcuma; CCRIS 3257; Diferulylmethane; Curcumin, >=94% (curcuminoid content), >=80% (Curcumin); NCGC00017159-04; SC-17381; BRD-K07572174-001-22-0; turmeric root oil hydrodistilled; Oils, curcuma; 458C377; Hydrastis; AK316302; Haldar, Souchet; Natural Yellow3; 4-08-00-03697 (Beilstein Handbook Reference); E 100 (Dye); 1,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-; CS-1490; Indian turmeric; (1E,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione); Kurkumin; Curcumin I; Souchet; (1E,6E)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione; HSDB 4334; Haidr; NCI-C61325; BBL027711; Golden seal; SCHEMBL13521974; CC0179; 1,3-Di(3-methoxy-4-hydroxystyryl)propanedial; Terra Merita; NCGC00258668-01; SBB006495; Curcumin, matrix substance for MALDI-MS, >=99.5% (HPLC); STL371943; AN-23454; CURCUMIN (SEE ALSO TUMERIC, OLEORESIN (10105-J)); 8024-37-1; Curcuma longa oils; 91884-86-5; AKOS001305497; BRD-K07572174-001-02-2; Turmeric extract; TURMERIC, OLEORESIN (CURCUMIN) (SEE ALSO CURCURMIN (458-37-7)); CI Natural Yellow 3; Cucurmin; CHEBI:3962; DTXSID8031077; DB-002681; Curcumine; Turmeric root oleoresin; curcumin; turmeric root oil CO2 extract; Curcumin, from Curcuma longa (Turmeric), powder; NCGC00017159-12; 79257-48-0; C.I. 75300; 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione; NSC 32982; SR-01000000149-5, curcumine;curcumin | IC21H20O6 | 368.4 g/mol | COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O |
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE007841 | INSRR | IRR | insulin receptor related receptor |
| TCMBANKGE014689 | CD38 | ADPRC 1; ADPRC1 | CD38 molecule |
| TCMBANKGE000562 | IL18 | IGIF; IL-18; IL-1g; IL1F4 | interleukin 18 |
| TCMBANKGE009434 | SNX1 | HsT17379; VPS5 | sorting nexin 1 |
| TCMBANKGE002442 | NT5E | CALJA; CD73; E5NT; NT; NT5; NTE; eN; eNT | 5'-nucleotidase ecto |
| TCMBANKGE000798 | MYD88 | MYD88D | MYD88 innate immune signal transduction adaptor |
| TCMBANKGE000742 | SMAD7 | CRCS3; MADH7; MADH8 | SMAD family member 7 |
| TCMBANKGE010692 | KAT5 | ESA1; HTATIP; HTATIP1; PLIP; TIP; TIP60; ZC2HC5; cPLA2 | lysine acetyltransferase 5 |
| TCMBANKGE009264 | RPSA | 37LRP; 67LR; ICAS; LAMBR; LAMR1; LBP; LBP/p40; LRP; LRP/LR; NEM/1CHD4; SA; lamR; p40 | ribosomal protein SA |
| TCMBANKGE009014 | MS4A1 | B1; Bp35; CD20; CVID5; LEU-16; MS4A2; S7 | membrane spanning 4-domains A1 |
| TCMBANKGE001089 | PARP1 | ADPRT; ADPRT 1; ADPRT1; ARTD1; PARP; PARP-1; PPOL; pADPRT-1 | poly(ADP-ribose) polymerase 1 |
| TCMBANKGE000195 | RASA1 | CM-AVM; CMAVM; CMAVM1; GAP; PKWS; RASA; RASGAP; p120; p120GAP; p120RASGAP | RAS p21 protein activator 1 |
| TCMBANKGE000955 | ABCC2 | ABC30; CMOAT; DJS; MRP2; cMRP | ATP binding cassette subfamily C member 2 |
| TCMBANKGE003081 | MPRIP | M-RIP; MRIP; RHOIP3; RIP3; p116Rip | myosin phosphatase Rho interacting protein |
| TCMBANKGE013166 | LANCL1 | GPR69A; p40 | LanC like 1 |
| TCMBANKGE000134 | EPO | DBAL; ECYT5; EP; MVCD2 | erythropoietin |
| TCMBANKGE001203 | MAPK1 | ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK | mitogen-activated protein kinase 1 |
| TCMBANKGE014979 | NOD2 | ACUG; BLAU; BLAUS; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1; YAOS | nucleotide binding oligomerization domain containing 2 |
| TCMBANKGE000032 | ARHGEF2 | GEF; GEF-H1; GEFH1; LFP40; Lfc; NEDMHM; P40 | Rho/Rac guanine nucleotide exchange factor 2 |
| TCMBANKGE008597 | HDAC11 | HD11 | histone deacetylase 11 |
| TCMBANKGE001179 | SMAD2 | JV18; JV18-1; MADH2; MADR2; hMAD-2; hSMAD2 | SMAD family member 2 |
| TCMBANKGE010752 | NT5C2 | GMP; NT5B; PNT5; SPG45; SPG65; cN-II | 5'-nucleotidase, cytosolic II |
| TCMBANKGE001026 | RIPK3 | RIP3 | receptor interacting serine/threonine kinase 3 |
| TCMBANKGE013942 | PERP | KCP1; KRTCAP1; PIGPC1; THW; dJ496H19.1 | p53 apoptosis effector related to PMP22 |
| TCMBANKGE001564 | HSPA8 | HEL-33; HEL-S-72p; HSC54; HSC70; HSC71; HSP71; HSP73; HSPA10; LAP-1; LAP1; NIP71 | heat shock protein family A (Hsp70) member 8 |
| TCMBANKGE000331 | CALCA | CALC1; CGRP; CGRP-I; CGRP-alpha; CGRP1; CT; KC; PCT | calcitonin related polypeptide alpha |
| TCMBANKGE004180 | CLDN2 | - | claudin 2 |
| TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
| TCMBANKGE001063 | CEBPB | C/EBP-beta; IL6DBP; NF-IL6; TCF5 | CCAAT enhancer binding protein beta |
| TCMBANKGE005641 | TRIM32 | BBS11; HT2A; LGMD2H; LGMDR8; TATIP | tripartite motif containing 32 |
| TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
| TCMBANKGE000619 | ASRGL1 | ALP; ALP1; CRASH | asparaginase and isoaspartyl peptidase 1 |
| TCMBANKGE009398 | SLC40A1 | FPN1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3 | solute carrier family 40 member 1 |
| TCMBANKGE013600 | DEFB4A | BD-2; DEFB-2; DEFB102; DEFB2; DEFB4; HBD-2; SAP1 | defensin beta 4A |
| TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
| TCMBANKGE003270 | IFITM3 | 1-8U; DSPA2b; IP15 | interferon induced transmembrane protein 3 |
| TCMBANKGE000280 | VIM | - | vimentin |
| TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
| TCMBANKGE000587 | ITGAM | CD11B; CR3A; MAC-1; MAC1A; MO1A; SLEB6 | integrin subunit alpha M |
| TCMBANKGE005040 | RABEPK | RAB9P40; bA65N13.1; p40 | Rab9 effector protein with kelch motifs |
| TCMBANKGE002159 | PDPN | AGGRUS; GP36; GP40; Gp38; HT1A-1; OTS8; PA2.26; T1A; T1A-2; T1A2; TI1A | podoplanin |
| TCMBANKGE014252 | IL15 | IL-15 | interleukin 15 |
| TCMBANKGE000394 | CXCR3 | CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR | C-X-C motif chemokine receptor 3 |
| TCMBANKGE001018 | MUC2 | MLP; MUC-2; SMUC | mucin 2, oligomeric mucus/gel-forming |
| TCMBANKGE001100 | MIR155 | MIRN155; miRNA155; mir-155 | microRNA 155 |
| TCMBANKGE004083 | SULT1A1 | HAST1/HAST2; P-PST; PST; ST1A1; ST1A3; STP; STP1; TSPST1 | sulfotransferase family 1A member 1 |
| TCMBANKGE011987 | TP63 | AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L | tumor protein p63 |
| TCMBANKGE005353 | NLRC4 | AIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; FCAS4; IPAF | NLR family CARD domain containing 4 |
| TCMBANKGE000109 | ACTB | BRWS1; PS1TP5BP1 | actin beta |
| TCMBANKGE012879 | DEFB1 | BD1; DEFB-1; DEFB101; HBD1 | defensin beta 1 |
| TCMBANKGE004611 | IL24 | C49A; FISP; IL10B; MDA7; MOB5; ST16 | interleukin 24 |
| TCMBANKGE000806 | HSPA4 | APG-2; HEL-S-5a; HS24/P52; HSPH2; RY; hsp70; hsp70RY | heat shock protein family A (Hsp70) member 4 |
| TCMBANKGE000729 | CASP1 | ICE; IL1BC; P45 | caspase 1 |
| TCMBANKGE002559 | CFH | AHUS1; AMBP1; ARMD4; ARMS1; CFHL3; FH; FHL1; HF; HF1; HF2; HUS | complement factor H |
| TCMBANKGE001012 | FOXP3 | AIID; DIETER; IPEX; JM2; PIDX; XPID | forkhead box P3 |
| TCMBANKGE004767 | ITGAE | CD103; HUMINAE | integrin subunit alpha E |
| TCMBANKGE000167 | EZR | CVIL; CVL; HEL-S-105; VIL2 | ezrin |
| TCMBANKGE000007 | IL12B | CLMF; CLMF2; IL-12B; IMD28; IMD29; NKSF; NKSF2 | interleukin 12B |
| TCMBANKGE000240 | IL17A | CTLA-8; CTLA8; IL-17; IL-17A; IL17 | interleukin 17A |
| TCMBANKGE001060 | YAP1 | COB1; YAP; YAP2; YAP65; YKI | Yes1 associated transcriptional regulator |
| TCMBANKGE001854 | CLEC12A | CD371; CLL-1; CLL1; DCAL-2; MICL | C-type lectin domain family 12 member A |
| TCMBANKGE012944 | PSMD7 | MOV34; P40; Rpn8; S12 | proteasome 26S subunit, non-ATPase 7 |
| TCMBANKGE001096 | TLR4 | ARMD10; CD284; TLR-4; TOLL | toll like receptor 4 |
| TCMBANKGE002355 | HAMP | HEPC; HFE2B; LEAP1; PLTR | hepcidin antimicrobial peptide |
| TCMBANKGE001341 | RGS2 | G0S8 | regulator of G protein signaling 2 |
| TCMBANKGE014671 | ADAR | ADAR1; AGS6; DRADA; DSH; DSRAD; G1P1; IFI-4; IFI4; K88DSRBP; P136 | adenosine deaminase RNA specific |
| TCMBANKGE003781 | UCHL5 | CGI-70; INO80R; UCH-L5; UCH37 | ubiquitin C-terminal hydrolase L5 |
| TCMBANKGE005378 | KRT20 | CD20; CK-20; CK20; K20; KRT21 | keratin 20 |
| TCMBANKGE008023 | LBP | BPIFD2 | lipopolysaccharide binding protein |
| TCMBANKGE010103 | OPTN | ALS12; FIP2; GLC1E; HIP7; HYPL; NRP; TFIIIA-INTP | optineurin |
| TCMBANKGE000421 | IL9 | HP40; IL-9; P40 | interleukin 9 |
| TCMBANKGE000624 | ALPL | AP-TNAP; APTNAP; HOPS; TNALP; TNAP; TNSALP | alkaline phosphatase, biomineralization associated |
| TCMBANKGE014322 | IL23A | IL-23; IL-23A; IL23P19; P19; SGRF | interleukin 23 subunit alpha |
| TCMBANKGE001168 | RIPK1 | AIEFL; IMD57; RIP; RIP-1; RIP1 | receptor interacting serine/threonine kinase 1 |
| TCMBANKGE000764 | TRPV1 | VR1 | transient receptor potential cation channel subfamily V member 1 |
| TCMBANKGE000420 | SPI1 | OF; PU.1; SFPI1; SPI-1; SPI-A | Spi-1 proto-oncogene |
| TCMBANKGE004208 | AXIN1 | AXIN; PPP1R49 | axin 1 |
滇IICP备16009434号-1 |
Dai SX Lab